Search research articles
Contact Us
Filters
Showing results (41-50 of 305) with videos related to
Page
of 31
Sort By:
Pharmacoepidemiology and Drug Safety
|
May 14, 2009
Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study
Raluca Ionescu-Ittu, Joseph A C Delaney, Michal Abrahamowicz
Annals of Epidemiology
|
November 27, 2012
Extreme maternal education and preterm birth: time-to-event analysis of age and nativity-dependent risks
Nathalie Auger, Michal Abrahamowicz, Alison L Park, et al.
Biometrical Journal. Biometrische Zeitschrift
|
December 2, 2017
On the necessity and design of studies comparing statistical methods
Anne-Laure Boulesteix, Harald Binder, Michal Abrahamowicz, et al.
Journal of Clinical Epidemiology
|
May 15, 2002
Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians
Erika Chang, Michal Abrahamowicz, Diane Ferland, et al.
Journal of Clinical Epidemiology
|
May 12, 2007
Simulations showed that validation of database-derived diagnostic criteria based on a small subsample reduced bias
Michal Abrahamowicz, Yongling Xiao, Raluca Ionescu-Ittu, et al.
Statistical Methods in Medical Research
|
September 22, 2021
Flexible extension of the accelerated failure time model to account for nonlinear and time-dependent effects of covariates on the hazard
Menglan Pang, Robert W Platt, Tibor Schuster, et al.
Drug Safety
|
July 1, 2017
Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance
Rolina D van Gaalen, Michal Abrahamowicz, David L Buckeridge
American Journal of Epidemiology
|
May 16, 2023
Comparison of Different Modeling Approaches for Prescription Opioid Use and Its Association With Adverse Events
Siyana Kurteva, Michal Abrahamowicz, Marie-Eve Beauchamp, et al.
Pharmacoepidemiology and Drug Safety
|
August 14, 2013
Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?
Michal Abrahamowicz, Marie-Eve Beauchamp, Pierre Fournier, et al.
Pharmacoepidemiology and Drug Safety
|
September 5, 2014
The impact of exposure model misspecification on signal detection in prospective pharmacovigilance
Rolina D van Gaalen, Michal Abrahamowicz, David L Buckeridge
Page
of 31
Search research articles
Search
Showing results (41-50 of 305) with videos related to
Sort By:
Page
of 31
Pharmacoepidemiology and Drug Safety
|
May 14, 2009
Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study
Raluca Ionescu-Ittu, Joseph A C Delaney, Michal Abrahamowicz
Annals of Epidemiology
|
November 27, 2012
Extreme maternal education and preterm birth: time-to-event analysis of age and nativity-dependent risks
Nathalie Auger, Michal Abrahamowicz, Alison L Park, et al.
Biometrical Journal. Biometrische Zeitschrift
|
December 2, 2017
On the necessity and design of studies comparing statistical methods
Anne-Laure Boulesteix, Harald Binder, Michal Abrahamowicz, et al.
Journal of Clinical Epidemiology
|
May 15, 2002
Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians
Erika Chang, Michal Abrahamowicz, Diane Ferland, et al.
Journal of Clinical Epidemiology
|
May 12, 2007
Simulations showed that validation of database-derived diagnostic criteria based on a small subsample reduced bias
Michal Abrahamowicz, Yongling Xiao, Raluca Ionescu-Ittu, et al.
Statistical Methods in Medical Research
|
September 22, 2021
Flexible extension of the accelerated failure time model to account for nonlinear and time-dependent effects of covariates on the hazard
Menglan Pang, Robert W Platt, Tibor Schuster, et al.
Drug Safety
|
July 1, 2017
Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance
Rolina D van Gaalen, Michal Abrahamowicz, David L Buckeridge
American Journal of Epidemiology
|
May 16, 2023
Comparison of Different Modeling Approaches for Prescription Opioid Use and Its Association With Adverse Events
Siyana Kurteva, Michal Abrahamowicz, Marie-Eve Beauchamp, et al.
Pharmacoepidemiology and Drug Safety
|
August 14, 2013
Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?
Michal Abrahamowicz, Marie-Eve Beauchamp, Pierre Fournier, et al.
Pharmacoepidemiology and Drug Safety
|
September 5, 2014
The impact of exposure model misspecification on signal detection in prospective pharmacovigilance
Rolina D van Gaalen, Michal Abrahamowicz, David L Buckeridge
Page
of 31